Spyre Therapeutics (SYRE) FCF Margin (QoQ) (2015 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 648,702.00 |
| Mar 31, 2023 | 189,156.00 |
| Dec 31, 2022 | -213,727.00 |
| Sep 30, 2022 | -535,266.00 |
| Jun 30, 2022 | -137,670.00 |
| Mar 31, 2022 | -140,222.00 |
| Dec 31, 2021 | -38,251.00 |
| Sep 30, 2021 | -16,716.00 |
| Jun 30, 2018 | 11,688.00 |
| Mar 31, 2018 | -12,767.00 |
| Dec 31, 2017 | 22,210.00 |
| Sep 30, 2017 | -18,823.00 |
| Jun 30, 2017 | 17,589.00 |
| Mar 31, 2017 | -22,181.00 |
| Dec 31, 2016 | 15,150.00 |
| Sep 30, 2016 | -16,660.00 |
| Jun 30, 2016 | 12,065.00 |
| Mar 31, 2016 | -40,941.00 |
| Dec 31, 2015 | 30,923.00 |
| Sep 30, 2015 | -25,164.00 |